Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2Skin Neoplasms 1Sarcoma, Kaposi 1Lymphoproliferative Disorders 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Colposcopy 18Imiquimod 14Conization 12Papillomavirus Vaccines 9Vaccines 7Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 7Cryotherapy 7Biopsy 6Acetic Acid 6human papillomavirus vaccine, L1 type 16, 18 5Vaginal Smears 5Papanicolaou Test 5Human Papillomavirus DNA Tests 5Blood Specimen Collection 5Watchful Waiting 4GX-188 vaccine 4Surveys and Questionnaires 3Cisplatin 3VGX-3100 2Transurethral Resection of Prostate 2Topotecan 2Spectrometry, Fluorescence 2Restraint, Physical 2Proflavine 2Polymerase Chain Reaction 2Paclitaxel 2Mass Screening 2Indomethacin 2Immunohistochemistry 2Human Papillomavirus Recombinant Vaccine nonavalent 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone × Clear all
NCT00285207 2010-10-11

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Tigris Pharmaceuticals

Phase 2 Completed
147 enrolled 6 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT00596258 2009-05-22

TG-003

Tigris Pharmaceuticals

Phase 2 Completed
11 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡